Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Crypto News: New Crypto Pepeto Announces Full Platform Completion While Solana Price Prediction Targets $1,000
-
Crypto News: Remittix Less Than $65K Away From $32M Launch Reveal as XRP Price Prediction Targets Powerful Recovery
-
Sugar & Spice For Couples App Launches on iPhone
-
Sugar & Spice For Couples App Launches on iPhone
-
New Crypto Pepeto Announces Binance-Veteran Developer Appointment With Three Products Live And Ethereum Price Prediction Targets $6,000
-
New Crypto: Remittix Targets a $0.50 Launch While the Ethereum Price Prediction Points Toward $6,000
-
Steward Group Launches New Independent Portfolio Management Firm in Partnership with Purpose Advisor Solutions
-
Stay Prepared for Canada's Grid Outages with Up to 65% Off Jackery Power Stations During Prime Big Deal Days' Early Access Event
-
Crypto News: Remittix Pushes Toward Its $36M Hard Cap as Bitcoin Price Prediction For September Hits $93K
-
Over 10,000 Units Sold: EVDANCE Unveils the Next-Generation NACS Charging Extension Cable
-
EVDANCE Unveils Affordable Smart EV Charger with Large Display and Premium Features
-
Apeing Advances to Stage 4 of $APEING Presale Following 200 Million+ Token Burn
-
MADD Canada Unveils New Prince Edward Island Provincial Memorial Monument Honouring Victims of Alcohol- and Drug-Related Crashes
-
Apeing Advances to Stage 4 Presale Following 200M+ Token Burn
-
CGTN：CGTN Poll | Why is the SCO Solution for Global Governance Drawing Wide Attention?
-
MISSION SUCCESS: Rocket Lab Launches 96th Electron Mission
-
yellowHEAD Introduces Mona, a Proprietary AI Creative Capability That Scales Ad Production for Client Campaigns
-
Citizens Commission on Human Rights International Issues Parent Recommendations on Psychiatric Drug and Hospital Risks
-
Ozi Amanat, Backer of Neuralink, SpaceX, xAI, Shield AI, Lambda, and Tenstorrent, Expands K2 Global’s Frontier Technology Investments
-
FortuneX Acquisition Corporation and WT Realty Group Inc. Announce Business Combination Agreement
-
Bend Duct Cleaning Uncovers Rodent Remains Behind an Odor Only Guests Noticed
-
Collective Metals Announces Management Changes
-
Liberty Gold Files Feasibility Study Technical Report for the Black Pine Project in Idaho, USA
-
XAI Floating Rate & Alternative Income Trust Announces Commencement of Tender Offer
-
Greenland Mines Applauds Historic U.S.-Denmark-Greenland Security Agreement, Reinforcing Greenland’s Strategic Importance to the United States
-
Skyworks Announces Extension of Expiration Date of Exchange Offers for Qorvo’s Senior Notes due 2029 and 2031
-
BIBLIOJAM ANNOUNCES APP THAT TURNS THE ENTIRE BIBLE INTO A YEARLONG MUSICAL EXPERIENCE
-
Millhouse The Christmas Mouse Brings Burnout-Free Holiday Magic to Families in 2026
-
Home BancShares, Inc. Announces Recognition in Forbes Top-Performing Banks and Bank Director RankingBanking
-
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
-
Johns Hopkins USFHP is One of the Highest-Rated Health Plans in the Nation
-
First Atlantic Nickel & Cobalt Raises 6.15 Million Dollars in No-Warrant, Non-Brokered Private Placement to Accelerate Mining Exploration and Development at Pipestone XL Nickel-Cobalt Alloy (Awaru
-
First Atlantic Nickel & Cobalt Raises 6.15 Million Dollars in No-Warrant, Non-Brokered Private Placement to Accelerate Mining Exploration and Development at Pipestone XL Nickel-Cobalt Alloy (Awaruite)
-
Univest Securities, LLC Announces Closing of $15.0 Million Registered Direct Offering for its Client ReTo Eco-Solutions, Inc. (NASDAQ: RETO)
-
Bastion Receives Conditional OCC Approval for a National Trust Bank Charter
-
New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients
-
Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare
-
Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophren
-
Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in
-
NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update
-
Enact Receives Ratings Upgrade from AM Best
-
Omega Flex, Inc. Announces Regular Quarterly Dividend for the Third Quarter 2026
-
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
for KING + COUNTRY Release Fifth Studio Album "the most beautiful colours"
-
for KING + COUNTRY Release Fifth Studio Album "the most beautiful colours"
-
Phoenix Energy Announces Distribution for Preferred Shares
-
Saratoga Investment Corp. Announces CFO Transition and New Leadership Appointments
-
HF Foods Group Announces Termination of At-The-Market Equity Offering Program
-
XCharge Reports First Half 2026 Unaudited Financial Results
-
LOBO TECHNOLOGIES LTD. Announces First Half of Fiscal Year 2026 Financial Results
